Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pusan National University Hospital
This is a prospective, single-arm, open-label study to assess evaluate the relevance of intratumoral washing by ultrathin bronchoscopy (outer diameter; 3mm) for detection of genetic alterations using Next Generation Sequencing in patients with NSCLC.
Age
20–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age ≥ 20 years
Obtained written informed consent
No contraindication to bronchoscopy
Subjects suspected of having lung cancer on computed tomography or diagnosed with lung cancer by histology or cytology
Subjects planning to undergo tissue or liquid biopsy for genetic alteration with Next Generation Sequencing
You may not be if
Subjects who withdraw informed consent
Subjects who are unable to undergo liquid biopsy (plasma) and tissue biopsy for genetic alteration with Next Generation Sequencing based on the investigator's judgement
Subjects diagnosed with a cancer other than non-small cell lung cancer from the lung tissue lesion
Subjects diagnosed with a benign lesion from the lung tissue lesion
Clareo Health | Feasibility of Bronchial Washing Fluid for Molecular Testing With Next Generation Sequencing in Lung Cancer
